ElringKlinger Valuation
Is ZIL2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ZIL2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ZIL2 (€4) is trading below our estimate of fair value (€25.7)
Significantly Below Fair Value: ZIL2 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ZIL2?
Key metric: As ZIL2 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is ZIL2's PS Ratio? | |
|---|---|
| PS Ratio | 0.1x |
| Sales | €1.79b |
| Market Cap | €252.49m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.3x |
| Enterprise Value/EBITDA | 3.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ZIL2's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.3x | ||
NVM Novem Group | 0.4x | 4.1% | €249.6m |
ED4 EDAG Engineering Group | 0.2x | 2.7% | €191.0m |
GMM Grammer | 0.04x | 4.2% | €80.5m |
SFQ SAF-Holland | 0.3x | 4.9% | €603.7m |
ZIL2 ElringKlinger | 0.1x | 2.1% | €253.4m |
Price-To-Sales vs Peers: ZIL2 is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.3x).
Price to Sales Ratio vs Industry
How does ZIL2's PS Ratio compare vs other companies in the European Auto Components Industry?
| 8 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 8 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: ZIL2 is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Auto Components industry average (0.3x).
Price to Sales Ratio vs Fair Ratio
What is ZIL2's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.1x |
| Fair PS Ratio | 0.1x |
Price-To-Sales vs Fair Ratio: ZIL2 is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €4.00 | €5.84 +46.0% | 27.7% | €8.50 | €4.00 | n/a | 5 |
| Nov ’25 | €4.11 | €6.38 +55.5% | 22.8% | €8.50 | €4.00 | n/a | 6 |
| Oct ’25 | €4.13 | €6.42 +55.4% | 17.9% | €8.00 | €4.70 | n/a | 6 |
| Sep ’25 | €4.20 | €6.83 +62.7% | 27.4% | €10.50 | €4.70 | n/a | 6 |
| Aug ’25 | €4.73 | €7.65 +61.9% | 28.2% | €12.00 | €5.50 | n/a | 6 |
| Jul ’25 | €5.06 | €7.65 +51.2% | 28.2% | €12.00 | €5.50 | n/a | 6 |
| Jun ’25 | €5.95 | €7.65 +28.6% | 28.2% | €12.00 | €5.50 | n/a | 6 |
| May ’25 | €6.68 | €7.90 +18.3% | 30.8% | €12.00 | €5.10 | n/a | 6 |
| Apr ’25 | €6.07 | €7.30 +20.3% | 39.0% | €12.00 | €4.00 | n/a | 6 |
| Mar ’25 | €5.26 | €7.30 +38.8% | 39.0% | €12.00 | €4.00 | n/a | 6 |
| Feb ’25 | €5.07 | €7.30 +44.0% | 39.0% | €12.00 | €4.00 | n/a | 6 |
| Jan ’25 | €5.52 | €7.47 +35.3% | 37.4% | €12.00 | €4.00 | n/a | 6 |
| Dec ’24 | €5.96 | €7.75 +30.1% | 35.7% | €12.00 | €4.00 | n/a | 6 |
| Nov ’24 | €5.16 | €8.13 +57.6% | 39.4% | €12.50 | €4.00 | €4.11 | 6 |
| Oct ’24 | €5.87 | €7.76 +32.2% | 35.3% | €12.50 | €5.00 | €4.13 | 5 |
| Sep ’24 | €5.98 | €7.76 +29.9% | 35.3% | €12.50 | €5.00 | €4.20 | 5 |
| Aug ’24 | €7.72 | €11.15 +44.4% | 22.7% | €14.00 | €8.00 | €4.73 | 5 |
| Jul ’24 | €8.25 | €12.00 +45.5% | 19.0% | €14.00 | €8.00 | €5.06 | 5 |
| Jun ’24 | €8.51 | €10.92 +28.3% | 29.3% | €14.00 | €5.50 | €5.95 | 6 |
| May ’24 | €10.17 | €10.50 +3.2% | 31.9% | €14.00 | €5.50 | €6.68 | 5 |
| Apr ’24 | €9.40 | €10.00 +6.4% | 29.6% | €14.00 | €5.50 | €6.07 | 6 |
| Mar ’24 | €8.78 | €9.00 +2.5% | 25.6% | €12.00 | €5.50 | €5.26 | 5 |
| Feb ’24 | €7.86 | €9.00 +14.6% | 29.6% | €13.00 | €5.50 | €5.07 | 6 |
| Jan ’24 | €6.96 | €9.00 +29.4% | 29.6% | €13.00 | €5.50 | €5.52 | 6 |
| Dec ’23 | €7.55 | €9.00 +19.2% | 29.6% | €13.00 | €5.50 | €5.96 | 6 |
| Nov ’23 | €7.29 | €9.42 +29.2% | 24.6% | €13.00 | €7.00 | €5.16 | 6 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Cooper-Standard Holdings
US$243.3m
Through its subsidiary, Cooper-Standard Automotive Inc., manufactures and sells sealing, fuel and brake delivery, and fluid transfer systems in the United States, Mexico, China, Poland, Canada, Germany, France, and internationally.
C31
US$13.30
7D
-15.3%
1Y
-22.2%
Toyoda Gosei
JP¥324.3b
Manufactures and sells automotive parts, optoelectronic products, and general industry products.
11T
JP¥15.50
7D
2.0%
1Y
-12.4%
Forvia
€1.5b
Manufactures and sells automotive technology solutions in France, Germany, other European countries, the Americas, Asia, and internationally.
FAU
€7.73
7D
-12.5%
1Y
-53.1%